BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17312057)

  • 1. Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.
    Sampson JH; Raghavan R; Provenzale JM; Croteau D; Reardon DA; Coleman RE; Rodríguez Ponce I; Pastan I; Puri RK; Pedain C
    AJR Am J Roentgenol; 2007 Mar; 188(3):703-9. PubMed ID: 17312057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.
    Kunwar S; Chang SM; Prados MD; Berger MS; Sampson JH; Croteau D; Sherman JW; Grahn AY; Shu VS; Dul JL; Husain SR; Joshi BH; Pedain C; Puri RK
    Neurosurg Focus; 2006 Apr; 20(4):E15. PubMed ID: 16709020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning.
    Sampson JH; Brady ML; Petry NA; Croteau D; Friedman AH; Friedman HS; Wong T; Bigner DD; Pastan I; Puri RK; Pedain C
    Neurosurgery; 2007 Feb; 60(2 Suppl 1):ONS89-98; discussion ONS98-9. PubMed ID: 17297371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.
    Kunwar S; Prados MD; Chang SM; Berger MS; Lang FF; Piepmeier JM; Sampson JH; Ram Z; Gutin PH; Gibbons RD; Aldape KD; Croteau DJ; Sherman JW; Puri RK;
    J Clin Oncol; 2007 Mar; 25(7):837-44. PubMed ID: 17327604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma.
    Parney IF; Kunwar S; McDermott M; Berger M; Prados M; Cha S; Croteau D; Puri RK; Chang SM
    J Neurosurg; 2005 Feb; 102(2):267-75. PubMed ID: 15739554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions.
    Sampson JH; Raghavan R; Brady ML; Provenzale JM; Herndon JE; Croteau D; Friedman AH; Reardon DA; Coleman RE; Wong T; Bigner DD; Pastan I; Rodríguez-Ponce MI; Tanner P; Puri R; Pedain C
    Neuro Oncol; 2007 Jul; 9(3):343-53. PubMed ID: 17435179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results.
    Vogelbaum MA; Sampson JH; Kunwar S; Chang SM; Shaffrey M; Asher AL; Lang FF; Croteau D; Parker K; Grahn AY; Sherman JW; Husain SR; Puri RK
    Neurosurgery; 2007 Nov; 61(5):1031-7; discussion 1037-8. PubMed ID: 18091279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.
    Kioi M; Husain SR; Croteau D; Kunwar S; Puri RK
    Technol Cancer Res Treat; 2006 Jun; 5(3):239-50. PubMed ID: 16700620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.
    Sampson JH; Akabani G; Archer GE; Berger MS; Coleman RE; Friedman AH; Friedman HS; Greer K; Herndon JE; Kunwar S; McLendon RE; Paolino A; Petry NA; Provenzale JM; Reardon DA; Wong TZ; Zalutsky MR; Pastan I; Bigner DD
    Neuro Oncol; 2008 Jun; 10(3):320-9. PubMed ID: 18403491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.
    Ferguson S; Lesniak MS
    Curr Drug Deliv; 2007 Apr; 4(2):169-80. PubMed ID: 17456036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model.
    Kawakami K; Kawakami M; Kioi M; Husain SR; Puri RK
    J Neurosurg; 2004 Dec; 101(6):1004-11. PubMed ID: 15597761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
    Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR
    J Neurosurg Pediatr; 2018 Dec; 23(3):333-342. PubMed ID: 30544335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convection-enhanced delivery in clinical trials.
    Hall WA; Rustamzadeh E; Asher AL
    Neurosurg Focus; 2003 Feb; 14(2):e2. PubMed ID: 15727423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas.
    Muro K; Das S; Raizer JJ
    Technol Cancer Res Treat; 2006 Jun; 5(3):201-13. PubMed ID: 16700617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of convection enhanced delivery of toxins in humans.
    Mehta AI; Choi BD; Raghavan R; Brady M; Friedman AH; Bigner DD; Pastan I; Sampson JH
    Toxins (Basel); 2011 Mar; 3(3):201-6. PubMed ID: 22069706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside.
    Husain SR; Puri RK
    J Neurooncol; 2003 Oct; 65(1):37-48. PubMed ID: 14649884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical tolerance of corticospinal tracts in convection-enhanced delivery to the brainstem.
    Morgenstern PF; Zhou Z; Wembacher-Schröder E; Cina V; Tsiouris AJ; Souweidane MM
    J Neurosurg; 2018 Dec; 131(6):1812-1818. PubMed ID: 30579270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging properties of convective delivery in diffuse intrinsic pontine gliomas.
    Chittiboina P; Heiss JD; Warren KE; Lonser RR
    J Neurosurg Pediatr; 2014 Mar; 13(3):276-82. PubMed ID: 24410126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies.
    Kunwar S
    Acta Neurochir Suppl; 2003; 88():105-11. PubMed ID: 14531568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy.
    Shimamura T; Husain SR; Puri RK
    Neurosurg Focus; 2006 Apr; 20(4):E11. PubMed ID: 16709016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.